COMPASS Pathways plc Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
COMPASS Pathways plc (CMPS) holds an ST Score of 36.0 out of 100 (C-), with its strongest factor being Momentum (A-) and its weakest Profitability (F). Analysts rate CMPS Buy across 15 ratings with a $18.63 average price target (+0.2% vs the current $15.01).
- Strongest
- MomentumA-
- Weakest
- ProfitabilityF
All factor grades
- MomentumA-
- ForecastB+
- ValuationC+
- GrowthC
- Financial StrengthD-
- ProfitabilityF
- Piotroski1/9
Contact
CMPS stock: frequently asked questions
What is CMPS's ST Score?
COMPASS Pathways plc (CMPS) has an ST Score of 36.0 out of 100, an overall grade of C-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CMPS a buy, sell, or hold?
Wall Street's consensus rating on CMPS is Buy based on 15 analyst ratings. Our own ST Score grades it C- (36.0/100). This is data, not investment advice — always do your own research.
What is CMPS's valuation grade?
COMPASS Pathways plc (CMPS) earns a valuation grade of C+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CMPS's growth grade?
COMPASS Pathways plc (CMPS) earns a growth grade of C, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CMPS's profitability grade?
COMPASS Pathways plc (CMPS) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CMPS's financial strength grade?
COMPASS Pathways plc (CMPS) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for CMPS?
The average analyst price target for COMPASS Pathways plc (CMPS) is $18.63 from 15 analysts, which is +0.2% versus the recent price of $15.01.
What is CMPS's Piotroski score?
COMPASS Pathways plc (CMPS) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.